← Leaderboards
Li Qiang
Columbia University Health Sciences
$4,092,700
Attributed
$4,853,400
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2013–22$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,853,400 · 5
By mechanism
R01$3,926,400 · 3
R00$747,000 · 1
K99$180,000 · 1
Top collaborators
- Weidong Wang2 shared
- Utpal Pajvani1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- David Dominguez-Sola$4,189,942
- Rudolph L Leibel$35,102,760
- Sway Peng Chen$159,343
- Utpal Pajvani$14,552,156
- Nicole Aaron$89,403
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroMetabolicAdipocytesIn VivoObesityInsulin Sensitizing DrugsGenesNon-Insulin-Dependent Diabetes MellitusMimeticsLiquid SubstanceEnergy MetabolismAdverse EffectsPost-Translational Protein ProcessingNuclear ReceptorsAgonistBone LossAcetylationInsulin SensitivityInsulin ResistanceDeacetylationAntidiabetic DrugsPpar GammaDiabetes MellitusWeight Gain
Grant awards (14)
Adipsin in NASH$582,698
R01 · FY2022 · DK
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment$462,522
R01 · FY2022 · DK
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis$400,000
R01 · FY2022 · DK · contact PI
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment$476,180
R01 · FY2021 · DK
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis$400,000
R01 · FY2021 · DK · contact PI
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis$405,000
R01 · FY2020 · DK · contact PI
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis$400,000
R01 · FY2020 · DK · contact PI
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis$400,000
R01 · FY2019 · DK · contact PI
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis$400,000
R01 · FY2018 · DK · contact PI
Brown Remodeling of White Adipose Tissue by PPARgamma Deacetylation$249,000
R00 · FY2017 · DK · contact PI
Brown Remodeling of White Adipose Tissue by PPARgamma Deacetylation$249,000
R00 · FY2016 · DK · contact PI
Brown Remodeling of White Adipose Tissue by PPARgamma Deacetylation$249,000
R00 · FY2015 · DK · contact PI
Brown Remodeling of White Adipose Tissue by PPARgamma Deacetylation$90,000
K99 · FY2014 · DK · contact PI
Brown Remodeling of White Adipose Tissue by PPARgamma Deacetylation$90,000
K99 · FY2013 · DK · contact PI